Cargando…
非小细胞肺癌驱动基因突变及靶向治疗的研究进展
Lung cancer is the leading cause of cancer-related mortality in the worldwide. The discovery of drive gene makes tumor treatment is no longer "one-size-fits-all". Targeted therapy to change the present situation of cancer drugs become "bullet" with eyes, the effect is visible and...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
中国肺癌杂志编辑部
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000403/ https://www.ncbi.nlm.nih.gov/pubmed/25342042 http://dx.doi.org/10.3779/j.issn.1009-3419.2014.10.07 |
Ejemplares similares
-
非小细胞肺癌EGFR基因靶向治疗研究进展
Publicado: (2017) -
非小细胞肺癌MET基因突变的机制及靶向药物研究进展
Publicado: (2020) -
晚期非小细胞肺癌ALK融合基因及其他少见驱动基因阳性靶向治疗进展
Publicado: (2017) -
晚期非小细胞肺癌HER2基因突变靶向治疗进展
Publicado: (2020) -
晚期非小细胞肺癌BRAF突变靶向治疗进展
Publicado: (2018)